Skip to main content
Clinical Trials/JPRN-UMIN000041069
JPRN-UMIN000041069
Recruiting
未知

Analysis on individual difference in pharmacokinetics of aprepitant and its metabolites, and investigation on predictive parameters of aprepitant response and adverse effects in Japanese patiens - Analysis on individual difference in pharmacokinetics of aprepitant and its metabolites, and investigation on predictive parameters of aprepitant response and adverse effects in Japanese patiens

Department of Hospital pharmacy Amaterasu University School of Medicine0 sites150 target enrollmentJuly 13, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
head and neck cancer
Sponsor
Department of Hospital pharmacy Amaterasu University School of Medicine
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 13, 2020
End Date
July 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Hospital pharmacy Amaterasu University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients discontinuing aprepitant 2\. Patients who are judged by physicians as inappropriate for study enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials